Correlation Between Pmv Pharmaceuticals and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Regeneron Pharmaceuticals.
Diversification Opportunities for Pmv Pharmaceuticals and Regeneron Pharmaceuticals
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pmv and Regeneron is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Regeneron Pharmaceuticals. In addition to that, Pmv Pharmaceuticals is 2.57 times more volatile than Regeneron Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest 83,134 in Regeneron Pharmaceuticals on November 28, 2024 and sell it today you would lose (12,918) from holding Regeneron Pharmaceuticals or give up 15.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Regeneron Pharmaceuticals
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Regeneron Pharmaceuticals |
Pmv Pharmaceuticals and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Regeneron Pharmaceuticals
The main advantage of trading using opposite Pmv Pharmaceuticals and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |